Trial intelligence / Profile preview

Volumetric Assessment of VCMX in Ridge Augmentation

NCT04873830Phase 1Completed

Sponsor
Ain Shams University
Start
Nov 2021
Primary completion
Mar 2023
Countries
1
01

Overview

Phase 1, randomised, open-label trial (2 arms), sponsored by Ain Shams University. Primary endpoint: Volumetric changes of soft tissue at implant sites at 9 months. Started Nov 2021; status: completed.

Beyond the preview

Go deeper on NCT04873830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04873830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call